Kraig Biocraft Laboratories Inc (KBLB)

[dragon_silk]

Exactly. Dilution. The uplist is dead for the time being. Not going to happen this spring. The R/S is not dead however. Notice how the company has passed on the opportunities to address the R/S elephant in the room ? Company has never been more desperate as now they are trying to sustain operations/ manufacturing without revenue. It was more manageable before as it was just r&d. Now, they are just bleeding from the jugular and need triage.